Construction of a label-free fluorescent biosensor for homogeneous detection of m6A eraser FTO in breast cancer tissues.

Ming-Hao Liu, Ning-Ning Zhao, Wan-Tong Yu, Jian-Ge Qiu, Bing-Hua Jiang, Yan Zhang, Chun-Yang Zhang

Talanta 2024 May 15

filter terms:

Fat mass and obesity-associated protein (FTO) is a crucial eraser of RNA N6- methyladenosine (m6A) modification, and abnormal FTO expression level is implicated in pathogenesis of numerous cancers. Herein, we demonstrate the construction of a label-free fluorescent biosensor for homogeneous detection of m6A eraser FTO in breast cancer tissues. When FTO is present, it specifically erases the methyl group in m6A, inducing the cleavage of demethylated DNA by endonuclease DpnII and the generation of a single-stranded DNA (ssDNA) with a 3'-hydroxyl group. Subsequently, terminal deoxynucleotidyl transferase (TdT) promotes the incorporation of dTTPs into the ssDNA to obtain a long polythymidine (T) DNA sequence. The resultant long poly (T) DNA sequence can act as a template to trigger hyperbranched strand displacement amplification (HSDA), yielding numerous DNA fragments that may be stained by SYBR Gold to produce an enhanced fluorescence signal. This biosensor processes ultrahigh sensitivity with a detection limit of 1.65 × 10-10 mg/mL (2.6 fM), and it can detect the FTO activity in a single MCF-7 cell. Moreover, this biosensor can screen the FTO inhibitors, evaluate enzyme kinetic parameters, and discriminate the FTO expression levels in the tissues of breast cancer patients and healthy persons. Copyright © 2024 Elsevier B.V. All rights reserved.

Citation

Ming-Hao Liu, Ning-Ning Zhao, Wan-Tong Yu, Jian-Ge Qiu, Bing-Hua Jiang, Yan Zhang, Chun-Yang Zhang. Construction of a label-free fluorescent biosensor for homogeneous detection of m6A eraser FTO in breast cancer tissues. Talanta. 2024 May 15;272:125784